You are here: Home » Companies » News
Business Standard

Madras HC orders formation of panel to ensure self-reliance in cancer drugs

In its judgment the court said India can not be dependent on China for APIs and ordered the formation of a five member committee to ensure self-reliance

Topics
cancer drugs | Madras High Court | pharmaceutical firms

T E Narasimhan  |  Chennai 

Madras High Court
The judge pointed out how cheap imported APIs, had turned India from being a pioneer in generics and pharmacy to the world to a mere formulations’ hub.

The Madras High Court's Justice N Kirubakaran has said that India has emerged as a pioneer in pharmaceuticals. Yet, for the basic ingredients of medicine making, it is heavily dependent on imports from China. This dependency handicaps us. It also makes our patients vulnerable if tensions escalate between the two countries. He also ordered formation of a 5-member committee to help bring foreign exchange for the country and to ensure India's self-reliance when it comes to

In his 226-page order Justice Kirubakaran on a couple of writ petitions moved by Chennai-based Vinkem Labs, directed the constitution of a committee comprising joint secretary-level officers from the Union Ministries of Pharmaceuticals and Finance in order to facilitate all necessary requirements, including financial needs, of the petitioner firm in carrying out its research on cancer cure.

Vinkem petitions have raised grievance over the lack of financial support from government, various banks and others, in carrying out generic research, said Justice Kirubakaran.

"We have already lost very capable brains to other countries by brain drain... it is time to retain the experts/scientists like petitioner by giving required support, more importantly trained support," he said.

In his order, he pointed out how cheap imported Active Pharmaceutical Ingredients (APIs), primarily from China, had turned India from being a pioneer in generics and pharmacy to the world to a mere formulations’ hub.

Citing larger concerns of public health the High Court proceeded to issue directions so that Vinkem Labs may become a global player. The court said that this was intended to achieve twin goals of bringing in foreign exchange for the country and to ensure India's self-reliance when it comes to

“Our country that had once built 99.7 per cent self-reliance in APIs went on to import over 90 per cent of its API requirements from China. The economic advantage of importing APIs has led India to lose its scientific edge and self-reliance in APIs,” the judge said.

The economic advantage of importing APIs has led India to lose its scientific edge and self-reliance in APIs and India now thrives as a mere finished dosage hub, that is, a country that imports its API requirements and bundles them into finished dosages. On account of this abdication of domestic segment, the patients of our country have to face issues such as proliferation of sub-standard drugs, unavailability of life saving drugs etc., At one stage, even the National Security Advisor (NSA) has cautioned the government of the danger to our national security on account of this excess import dependence from a single nation, the Judge said in the order.

"Gradually, on account of import of API requirements at cheap costs, our country has declined to a mere formulations hub," said the Judge, adding that “our country is not investing much in research and researchers are not encouraged.”

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, October 09 2020. 12:53 IST
RECOMMENDED FOR YOU
.